Member Exclusive

Novel prodrug used to precisely target lung cancer

A new anti-EGFR drug has been developed by researchers at the University of Colorado Anschutz Medical Campus that will precisely target tumors thanks to its attached ‘tail’.

Go to the profile of RxNet
Nov 02, 2017

Please sign in or register for FREE

No comments yet.